TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a research report report published on Thursday morning. The firm issued a hold rating on the stock.

TherapeuticsMD Stock Up 2.0 %

TXMD stock opened at $1.01 on Thursday. The business has a 50 day moving average of $0.92 and a 200 day moving average of $1.17. TherapeuticsMD has a twelve month low of $0.70 and a twelve month high of $2.44.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.